19.10.2020 12:47:51
|
Centogene: FDA Issues Emergency Use Authorization For SARS-CoV-2 RT-PCR Assay
(RTTNews) - Centogene N.V. (CNTG) said the FDA has issued Emergency Use Authorization for CentoSure, the company's SARS-CoV-2 RT-PCR test. CentoSure SARS-CoV-2 RT-PCR assay is a real-time test based on the reverse transcription polymerase chain reaction for the qualitative detection of SARS-CoV-2, the virus causing COVID-19.
Arndt Rolfs, CEO of CENTOGENE, said, "This emergency use authorization by the FDA is an extremely important further step to prevent a further spread of COVID-19, specifically in countries that have been heavily impacted, like the U.S.".
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Centogenemehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Centogenemehr Analysen
Aktien in diesem Artikel
Centogene | 0,14 | 7,92% |
|